Oral Maintenance Anti-Hypertensives for Severe Systolic Hypertension: A Controlled Before-and-After Quality Improvement Study
American Journal of Perinatology · 03.11.2026
DOI: 10.1055/a-2989-1511 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, online erschienen am 03.11.2026. Verfasst von Kristen A Cagino und 11 weiteren Autor:innen. Beteiligte Einrichtung: McGovern Medical School at UTHealth, The University of Texas Health Sciences Center at Houston, Department of Obstetrics, Gynecology and Reproductive…. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
A systolic blood pressure (SBP) threshold ≥ 160 mm Hg is used in pregnancy for acute antihypertensive treatment; however, this was initially adapted from expert opinion, and guidelines for nonpregnant adults support an SBP ≥ 180 mm Hg. We compared adverse maternal outcomes using a SBP threshold of ≥ 180 mm Hg versus ≥ 160 mm Hg for acute anti-hypertensive treatment, while treating SBPs between 160 and 179 mm Hg (diastolic blood pressure [DBP] < 110) with oral maintenance anti-hypertensives. We performed a quality improvement before-and-after noninferiority study (NCT05881252) of singletons ≥ 20 weeks' with SBP ≥ 160 mm Hg at a single level 4 medical center. In the before group, acute antihypertensives (intravenous [IV] labetalol/hydralazine or rapid-acting oral nifedipine) were given for persistent SBP ≥ 160 mm Hg (or DBP ≥ 110). In the after group, oral maintenance antihypertensives (labetalol or extended-release nifedipine) were given if persistent SBP was between 160 and 179 mm Hg (DBP < 110) and acute antihypertensives for persistent SBP ≥ 180 mm Hg (or DBP ≥ 110). The primary outcome was a composite of congestive heart failure, pulmonary edema, cerebrovascular accident, acute kidney injury, or myocardial infarction. Bayesian analysis was performed using a noninferiority margin of 4 and 1% (post hoc sensitivity analysis). We studied 1,002 individuals (410 in before; 592 in after) with severe hypertension. The primary outcome occurred in 2.9% of the before group and 1.9% of the after group (0.72: median relative risk, 95% credible interval: 0.36–1.46), with an 82% probability of risk reduction in the after group and > 99.9% probability that the risk difference in the after group was < 4% (99% for a 1% margin). Use of acute antihypertensives per individual treated decreased almost threefold in the after group (mean: 1.7 doses vs. 0.6, p < 0.01) In our population, treating SBPs between 160 and 180 mm Hg with oral maintenance antihypertensives resulted in a noninferior rate of maternal adverse outcomes and decreased the use of IV/rapid acting medication.
Autor:innen und Institutionen
- McGovern Medical School at UTHealth, The University of Texas Health Sciences Center at Houston, Department of Obstetrics, Gynecology and Reproductive Sciences, Texas, United States, Houston.
- McGovern Medical School at UTHealth, The University of Texas Health Sciences Center at Houston, Center for Clinical Research and Evidence-Based Medicine, Texas, United States, Houston.
- Delaware Center of Maternal-Fetal Medicine, Department of Maternal-Fetal Medicine, Delaware, United States, Newark.
ORCID-Profile: Kristen A Cagino, Sean C Blackwell
Zitieren
APA
Cagino, K. A., Becker, C., Hyde, E., Cortes, C., Chartier, A., Red, B., Pedroza, C., Huang, C., Chauhan, S. P., Mendez-Figueroa, H., Blackwell, S. C., & Sibai, B. M. (2026). Oral Maintenance Anti-Hypertensives for Severe Systolic Hypertension: A Controlled Before-and-After Quality Improvement Study. American Journal of Perinatology. https://doi.org/10.1055/a-2989-1511
Vancouver
Cagino KA, Becker C, Hyde E, Cortes C, Chartier A, Red B, et al. Oral Maintenance Anti-Hypertensives for Severe Systolic Hypertension: A Controlled Before-and-After Quality Improvement Study. American Journal of Perinatology. 2026. doi:10.1055/a-2989-1511
BibTeX
@article{Cagino2026,
author = {Cagino, Kristen A and Becker, Cabrina and Hyde, Emily and Cortes, Christina and Chartier, Anthony and Red, Beverly and Pedroza, Claudia and Huang, Chenyue and Chauhan, Suneet P and Mendez-Figueroa, Hector and Blackwell, Sean C and Sibai, Baha M},
title = {Oral Maintenance Anti-Hypertensives for Severe Systolic Hypertension: A Controlled Before-and-After Quality Improvement Study},
journal = {American Journal of Perinatology},
year = {2026},
doi = {10.1055/a-2989-1511}
}
EUVIMED